Of the three genome-wide suggestive probes (Table 1, Additional file 1), cg27094856 was located in the fourth intron of the AXL gene, which is implicated in many cancers and is a therapeutic target for antibody-based therapies [35–37]. The gene discussed is AXL; the disease is cancer.